Wednesday Miracle Drug Open Comments

Is there nothing that this medicine can’t do?  Parasites, viruses, now cancer?  But since it’s a cheap drug and Big Pharma can’t make money off of it, it’ll be hard to find a doctor who’ll prescribe it.  I may have to follow this guy’s Substack.

Ivermectin Squares Off in a New War on Cancer

RESCUE with Michael Capuzzo

With this article, I begin what I hope will be a series of reports on the use of inexpensive generic drugs for the treatment of cancer. In one of the few good things to come out of the SARS-CoV-2 pandemic, a growing number of physicians who pioneered effective early treatments for Covid-19 is now attempting to learn if safe, off-patent drugs can also work for cancer. So far, results are promising for drugs like ivermectin, mebendazole, and metformin, and supplements like melatonin.

John Ross was fifty-one years old when he was diagnosed, after more than a year of discomfort and growing unwellness, with Stage 3B colon cancer. A three- to four-inch tumor had almost completely blocked and broken through the organ wall; his surrounding lymph nodes were enlarged and presumed cancerous.

The story of John Ross goes on to describe how he pursued “conventional” cancer treatments, but didn’t tell his doctors he was also using ivermectin and other non-conventional treatments:

In his quest for the best care, Ross, who lives in Prescott, Wisconsin, went to two major cancer centers in the Midwest. He underwent a battery of blood draws and diagnostic tests and consulted at least a dozen physicians. But only Dr. James found and treated, he said, a low magnesium level, a Vitamin D level that was acceptable but too low, Dr. James believed, for challenging cancer, and, most critically, severe thyroid dysfunction. Nobody had tested for this, he said.

“I don’t know how you are standing here today—I’ve never seen blood this bad,” Dr. James told Ross after his thyroid result came in….” Starting three weeks before radiation and chemotherapy, Ross began, along with ivermectin, infusions of high-dose Vitamin C and glutathione; major auto-hemotherapy, also called ozone therapy; and hyperbaric oxygen therapy, along with supplements like high-dose melatonin.

The “conventional” doctors were amazed at his lack of adverse reactions to the harsh chemicals and radiation he was being given. No burns, no hair loss, etc.

The clincher, however, came in Ross’s MRI and CT scans in July of 2023. After twenty-eight radiation and chemotherapy treatments and nearly three months of the ivermectin protocol, “Ninety percent of his tumor had turned fibrous, meaning into scar tissue,” Ross’s wife, Roxanne, told me. “And the lymph nodes were half the size,” John added. An oncologist’s report called that an “excellent response.”

Dr. James saw this kind of recovery with two patients, the other one withholding his name.  The anonymous patient totally refused the “conventional”  treatment and took only the cheap stuff.

Same result.

Two years before Covid, researchers analyzed published data that strongly suggested ivermectin could be repurposed, namely put to another off-label use, for cancer. In about twenty laboratory studies, ivermectin was found to inhibit cell proliferation and induce “apoptosis”—cell death—in cancer cell lines of the breast, prostate, ovary, head and neck, colon, and pancreas. 

/snip

A seasoned group of expert doctors—often sharing their experiences in chat groups, tweets, and texts—is challenging the American model of cancer care. One patient at a time, they are using safe, off-the-shelf drugs, often alongside traditional therapies. I know of losses to cancer among their patients. But I also know of unexpected wins.

Dr. Paul Marik is a widely published critical care physician and author of a book on the potential of so-called repurposed drugs to prevent and treat cancer. Dr. Kathleen Ruddy is a retired cancer surgeon who trained at Memorial Sloan-Kettering and cared for 10,000 breast cancer patients over a thirty-year career.

/snip

Mebendazole and ivermectin, both antiparasitic drugs, doom cancer cells by disrupting the biochemical pathways on which they depend, Marik explained of the research. “They act on tumor stem cells and the tumor microenvironment. Unlike chemo, which only targets rapidly dividing cells, both ivermectin and mebendazole have been proven to act on multiple tumor pathways involving multiple different cancer types.”

“In the pre-clinical data, the twenty years of research that Paul is referring to,” Ruddy said, “there is not a cancer type that has not been impinged upon in terms of its growth and proliferation when exposed to ivermectin. Not one. Not one,” she said, gesturing with her index finger. All have succumbed, to varying degrees, when exposed to ivermectin.

There’s more, but you get the idea.

The idea of affordable cancer care that works as well or better than the multiple thousands dollars treatments? And you thought the real estate market was going to be decimated.  Just imagine all the cancer docs having to change specialties, the pharmacy reps finding new drugs to hawk…and all the mommies and daddies being able to hug their kids for years to come.